Dr. Arinzeh received her B.S. from Rutgers University, New Brunswick, NJ in Mechanical Engineering, her M.S.E. in Biomedical Engineering from JohnsHopkinsUniversity, and her Ph.D. in Bioengineering from the University of Pennsylvania. She worked for several years as a project manager at a stem cell technology company, Osiris Therapeutics, Inc. Dr. Arinzeh joined the faculty of the New Jersey Institute of Technology (NJIT) in 2001 as one of the founding faculty members of the department of Biomedical Engineering. Her most notable or cited work to date has been in the use of allogeneic MSCs to induce bone formation in a large bone defect without the use of immunosuppressive therapy.
This study demonstrated the potential use of allogeneic MSCs in long bone repair as an off-the-shelf therapy and served the basis for FDA approval to pursue clinical trials using allogeneic MSCs for various applications. Dr. Arinzeh has been recognized with numerous awards, including the National Science Foundation CAREER Award in 2003, Presidential Early Career Award for Scientists and Engineers (PECASE) in 2004, Outstanding Scientist Award from the NJ Association for Biomedical Research in 2004, People to Watch in 2005 in The Star Ledger and the Coulter Foundation Translational Award in 2010.